Provectus Biopharma (PVCT) Reports Q2 Loss of $0.02/Share

August 11, 2016 9:29 AM EDT
Get Alerts PVCT Hot Sheet
Price: $0.02 --0%

Financial Fact:
Research and development: 2.46M

Today's EPS Names:
PG, CFG, GE, More
Trade PVCT Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Provectus Biopharma (NYSE: PVCT) reported Q2 EPS of ($0.02), versus ($0.02) reported last year.

Our cash and cash equivalents were $4,891,313 at June 30, 2016, compared with $9,760,997 at March 31, 2016.

For earnings history and earnings-related data on Provectus Biopharma (PVCT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment